Literature DB >> 11413292

Fidelity of leader and trailer sequence usage by the respiratory syncytial virus and avian pneumovirus replication complexes.

A C Marriott1, J M Smith, A J Easton.   

Abstract

The specificity of usage of promoters for replication and transcription by the pneumoviruses human respiratory syncytial virus (HRSV) and avian pneumovirus (APV) was studied using minigenomes containing a reporter gene. When infectious HRSV or APV was used as helper virus, replication could occur only if both the leader and trailer regions (containing the replicative and transcriptional promoters) were derived from the helper virus. In contrast, when the HRSV replication complex was supplied from cDNA plasmids, a minigenome containing either the APV leader or trailer was recognized and substantial levels of replication and transcription occurred. These data suggest that in pneumovirus-infected cells, helper virus functions can discriminate between genomes on the basis of the terminal sequences and that there is an association between the leader and trailer required for productive replication. This association is required only in virus-infected cells, not when replication and transcription are mediated by plasmid-directed expression of the component proteins required for replication and transcription. The possible implications of this are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413292      PMCID: PMC114348          DOI: 10.1128/JVI.75.14.6265-6272.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  The bulk of the phosphorylation of human respiratory syncytial virus phosphoprotein is not essential but modulates viral RNA transcription and replication.

Authors:  N Villanueva; R Hardy; A Asenjo; Q Yu; G Wertz
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

2.  Mutations in the 5' trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step.

Authors:  M E Peeples; P L Collins
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Rescue of a foreign gene by Sendai virus.

Authors:  K H Park; T Huang; F F Correia; M Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

4.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

5.  Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene.

Authors:  P L Collins; M A Mink; D S Stec
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

6.  Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.

Authors:  R Fearns; P L Collins
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Rescue of a bovine respiratory syncytial virus genomic RNA analog by bovine, human and ovine respiratory syncytial viruses confirms the "functional integrity" and "cross-recognition" of BRSV cis-acting elements by HRSV and ORSV.

Authors:  A S Yunus; S Krishnamurthy; M K Pastey; Z Huang; S K Khattar; P L Collins; S K Samal
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

8.  Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus.

Authors:  R Fearns; P L Collins; M E Peeples
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  Infectious defective interfering particles of VSV from transcripts of a cDNA clone.

Authors:  A K Pattnaik; L A Ball; A W LeGrone; G W Wertz
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

10.  Cloning and sequencing of the matrix protein (M) gene of turkey rhinotracheitis virus reveal a gene order different from that of respiratory syncytial virus.

Authors:  Q Yu; P J Davis; J Li; D Cavanagh
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

View more
  7 in total

1.  Evidence that the respiratory syncytial virus polymerase is recruited to nucleotides 1 to 11 at the 3' end of the nucleocapsid and can scan to access internal signals.

Authors:  Vanessa M Cowton; Rachel Fearns
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Evidence that the polymerase of respiratory syncytial virus initiates RNA replication in a nontemplated fashion.

Authors:  Sarah L Noton; Vanessa M Cowton; Chadene R Zack; David R McGivern; Rachel Fearns
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

3.  Mapping the transcription and replication promoters of respiratory syncytial virus.

Authors:  Rachel Fearns; Mark E Peeples; Peter L Collins
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  The first two nucleotides of the respiratory syncytial virus antigenome RNA replication product can be selected independently of the promoter terminus.

Authors:  Sarah L Noton; Rachel Fearns
Journal:  RNA       Date:  2011-08-30       Impact factor: 4.942

5.  Characterization of the Interaction Domains between the Phosphoprotein and the Nucleoprotein of Human Metapneumovirus.

Authors:  Hortense Decool; Benjamin Bardiaux; Luis Checa Ruano; Olivier Sperandio; Jenna Fix; Irina Gutsche; Charles-Adrien Richard; Monika Bajorek; Jean-François Eléouët; Marie Galloux
Journal:  J Virol       Date:  2021-11-03       Impact factor: 6.549

Review 6.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Identification of amino acids that are critical to the processivity function of respiratory syncytial virus M2-1 protein.

Authors:  Helen Zhou; Xing Cheng; Hong Jin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.